Essilor International SA (ESLOY) Stock Rating Lowered by Zacks Investment Research
Zacks Investment Research downgraded shares of Essilor International SA (NASDAQ:ESLOY) from a hold rating to a strong sell rating in a research report released on Wednesday.
According to Zacks, “Essilor International researches, develops, manufactures and markets around the world a wide range of lenses to improve and protect eyesight. It creates lenses for various types of visual disorders such as myopia, hypermetropia, presbyopia and stigmatism. The group’s know-how also covers the manufacture and sale of optical instruments mainly machines used to edge finished lenses and diagnose visual disorders. The Company sells its products through various flagship brands such as Varilux, Crizal, Essilor, Definity and Xperio. Essilor International is headquartered in Charenton-le-Pont, France. “
Separately, Royal Bank of Canada started coverage on Essilor International SA in a research report on Thursday, September 21st. They issued an underperform rating for the company.
Essilor International SA (ESLOY) opened at $61.60 on Wednesday. Essilor International SA has a twelve month low of $50.35 and a twelve month high of $68.43.
About Essilor International SA
Essilor International SA, formerly Essilor International Compagnie Generale D’Optique SA, is a France-based ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Essilor International SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Essilor International SA and related companies with Analyst Ratings Network's FREE daily email newsletter.